AXIM Biotechnologies, Inc. is a Nevada-based developer of diagnostic healthcare solutions focused on eye health and SARS-CoV-2 neutralizing antibody tests. The company owns two FDA-cleared 510(k) lateral flow assay tests for dry eye disease (DED), measuring Lactoferrin and IgE biomarkers in human tears at point-of-care. Core competencies include rapid lateral flow immunoassays, reagents, and monoclonal antibody development. Products are distributed via an exclusive global commercialization agreement with Versa Ophthalmics, LLC.
Q2 FY2026 — expected 2026-09-18
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2024-04-16 | 2023-12-31 | 0001096906-24-000864 | EDGAR | 54K words |
| 2023-04-17 | 2022-12-31 | 0001096906-23-000858 | EDGAR | 75K words |
| 2022-04-15 | 2021-12-31 | 0001096906-22-000886 | EDGAR | 84K words |
| 2021-04-15 | 2020-12-31 | 0001078782-21-000365 | EDGAR | — |
| 2020-05-14 | 2019-12-31 | 0001078782-20-000331 | EDGAR | — |
| 2019-04-08 | 2018-12-31 | 0001078782-19-000304 | EDGAR | — |
| 2018-03-15 | 2017-12-31 | 0001078782-18-000306 | EDGAR | — |
| 2017-04-17 | 2016-12-31 | 0001078782-17-000498 | EDGAR | — |
| 2016-04-14 | 2015-12-31 | 0001387308-16-000187 | EDGAR | — |
| 2015-04-14 | 2014-12-31 | 0001387308-15-000034 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2024-08-19 | 2024-06-30 | 0001096906-24-001772 | EDGAR | 43K words |
| 2024-05-20 | 2024-03-31 | 0001096906-24-001202 | EDGAR | 40K words |
| 2023-11-20 | 2023-09-30 | 0001096906-23-002238 | EDGAR | 40K words |
| 2023-08-21 | 2023-06-30 | 0001096906-23-001655 | EDGAR | 39K words |
| 2023-05-22 | 2023-03-31 | 0001096906-23-001168 | EDGAR | 40K words |
| 2022-11-14 | 2022-09-30 | 0001096906-22-002767 | EDGAR | 46K words |
| 2022-08-16 | 2022-06-30 | 0001096906-22-001922 | EDGAR | 47K words |
| 2022-05-23 | 2022-03-31 | 0001096906-22-001257 | EDGAR | 44K words |
| 2021-11-22 | 2021-09-30 | 0001096906-21-002816 | EDGAR | — |
| 2021-08-23 | 2021-06-30 | 0001096906-21-002137 | EDGAR | — |
| 2021-05-24 | 2021-03-31 | 0001078782-21-000487 | EDGAR | — |
| 2020-11-20 | 2020-09-30 | 0001078782-20-000900 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2024-10-15 | 0001096906-24-002002 | EDGAR | 1K words |
| 2024-03-21 | 0001096906-24-000539 | EDGAR | 2K words |
| 2024-02-13 | 0001096906-24-000199 | EDGAR | 1K words |
| 2023-12-28 | 0001096906-23-002456 | EDGAR | 3K words |
| 2023-06-02 | 0001096906-23-001228 | EDGAR | 11K words |
| 2023-05-30 | 0001096906-23-001206 | EDGAR | 2K words |
| 2023-05-25 | 0001096906-23-001188 | EDGAR | 3K words |
| 2023-01-27 | 0001096906-23-000219 | EDGAR | 3K words |
| 2022-09-19 | 0001096906-22-002280 | EDGAR | 1K words |
| 2022-08-29 | 0001096906-22-002035 | EDGAR | 1K words |
154 total filings indexed. 122 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001514946 |
| Ticker | AXIM |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | NV |
| Headquarters | San Diego, CA |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/AXIM (~200 tokens, structured JSON with cryptographic provenance)